Robert Paul Marvenko is a Baltimore, Maryland based male chiropractor who is specialized as General Chiropractor. Active license number of Robert Paul Marvenko as General Chiropractor is S01917 in Maryland. Robert Paul Marvenko is qualified as a Doctor of Chiropractic (D.C.), licensed by the State and who practices chiropractic medicine -that discipline within the healing arts which deals with the nervous system and its relationship to the spinal column and its interrelationship with other body systems.
Complete Profile:
Robert Paul Marvenko speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Chiropractor
Credentials:
DC
Gender:
Male
Practice Address:
8305 Liberty Rd, Baltimore, Maryland, 21244-3125
Phone:
410-922-4341
Fax:
410-922-5727
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1003958547
NPI Enumeration Date:
13 Feb, 2007
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Robert Paul Marvenko are as mentioned below.
License Number
Specialization
State
Status
S01917
Chiropractor
Maryland
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
8305 Liberty Rd, Baltimore, Maryland
Zip:
21244-3125
Phone Number:
410-922-4341
Fax Number:
410-922-5727
Patients can reach Robert Paul Marvenko at 8305 Liberty Rd, Baltimore, Maryland or can call to book an appointment on 410-922-4341. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.